These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25529476)

  • 1. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
    Holmgren G; Synnergren J; Bogestål Y; Améen C; Åkesson K; Holmgren S; Lindahl A; Sartipy P
    Toxicology; 2015 Feb; 328():102-11. PubMed ID: 25529476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.
    Zhang L; Xu MX; Yin QS; Zhu CY; Cheng XL; Ren YR; Zhuang PW; Zhang YJ
    Toxicol Lett; 2017 Feb; 268():17-25. PubMed ID: 28099878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data.
    Holmgren G; Sartipy P; Andersson CX; Lindahl A; Synnergren J
    Toxicol Sci; 2018 May; 163(1):182-195. PubMed ID: 29385562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment.
    Chaudhari U; Nemade H; Wagh V; Gaspar JA; Ellis JK; Srinivasan SP; Spitkovski D; Nguemo F; Louisse J; Bremer S; Hescheler J; Keun HC; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Nov; 90(11):2763-2777. PubMed ID: 26537877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
    Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
    Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
    Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells.
    Andersson H; Steel D; Asp J; Dahlenborg K; Jonsson M; Jeppsson A; Lindahl A; Kågedal B; Sartipy P; Mandenius CF
    J Biotechnol; 2010 Oct; 150(1):175-81. PubMed ID: 20633583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
    Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H
    Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes.
    Louisse J; Wüst RCI; Pistollato F; Palosaari T; Barilari M; Macko P; Bremer S; Prieto P
    Toxicol In Vitro; 2017 Aug; 42():182-190. PubMed ID: 28456566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Ellis JK; Wagh V; Nemade H; Hescheler J; Keun HC; Sachinidis A
    Amino Acids; 2017 Dec; 49(12):1955-1963. PubMed ID: 28421296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory mechanisms of myogenin expression in doxorubicin-treated rat cardiomyocytes.
    Liu ST; Huang SM; Ho CL; Yen LC; Huang CJ; Lin WS; Chan JY
    Oncotarget; 2015 Nov; 6(35):37443-57. PubMed ID: 26452256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes.
    Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS
    Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse embryonic stem cells irradiated with γ-rays differentiate into cardiomyocytes but with altered contractile properties.
    Rebuzzini P; Fassina L; Mulas F; Bellazzi R; Redi CA; Di Liberto R; Magenes G; Adjaye J; Zuccotti M; Garagna S
    Mutat Res; 2013 Aug; 756(1-2):37-45. PubMed ID: 23792212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells.
    Gao X; Sprando RL; Yourick JJ
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):43-51. PubMed ID: 26006729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs.
    Adamcova M; Skarkova V; Seifertova J; Rudolf E
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.